Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:227-232

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Caterina, R.
Right arrow Articles by Liao, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Caterina, R.
Right arrow Articles by Liao, J. K.
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Growth factors/cytokines
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:227.)
© 2001 American Heart Association, Inc.


Vascular Biology

Induction of Endothelial-Leukocyte Interaction by Interferon-{gamma} Requires Coactivation of Nuclear Factor-{kappa}B

Raffaele De Caterina; Todd Bourcier; Ulrich Laufs; Vito La Fata; Guido Lazzerini; Andrew S. Neish; Peter Libby; James K. Liao

From the Vascular Medicine Unit (T.B., U.L., V.L.F., P.L., J.K.L.), Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass; the CNR Institute of Clinical Physiology (R.D.C., G.L.), Pisa, and the Cardiovascular Division (R.D.C., G.L.), "G. D’Annunzio" University, Chieti, Italy; and the Department of Pathology (A.S.N.), Emory University Hospital, Atlanta, Ga.

Correspondence to James K. Liao, MD, Vascular Medicine and Atherosclerosis Unit, Brigham and Women’s Hospital, 221 Longwood Ave, LMRC-322, Boston, MA 02115. E-mail jliao{at}rics.bwh.harvard.edu

Abstract—To determine whether nuclear factor (NF)-{kappa}B is necessary to confer endothelial cell responsiveness to interferon (INF)-{gamma} in terms of vascular cell adhesion molecule (VCAM)-1 expression and leukocyte adhesion, human endothelial cells were treated with IFN-{gamma} in the presence of low concentrations (LCs) of interleukin (IL)-1{alpha} (<=100 pg/mL), which activates NF-{kappa}B but does not induce VCAM-1 expression. Although IFN-{gamma} induced major histocompatibility complex class II antigen expression and although a high concentration of IL-1{alpha} (10 ng/mL) induced leukocyte adhesion and VCAM-1 expression, neither IFN-{gamma} nor LC IL-1{alpha} was able to induce VCAM-1 expression or leukocyte adhesion. However, the combination of IFN-{gamma} and LC IL-1{alpha} induced VCAM-1 expression and increased leukocyte adhesion (67% and 49% of high-concentration IL-1{alpha}, respectively). Electrophoretic mobility shift assays and immunoblotting of nuclear extracts showed that IFN-{gamma} activated signal transducers and activators of transcription (STAT)-1{alpha} and interferon regulatory factor (IRF)-1 but not NF-{kappa}B, whereas LC IL-1{alpha} activated NF-{kappa}B but not STAT-1{alpha} or IRF-1. Nuclear run-on studies showed that LC IL-1{alpha} is necessary but not sufficient for inducing VCAM-1 gene transcription and that the combination of IFN-{gamma} and LC IL-1{alpha} is required for full VCAM-1 gene transcription. These findings suggest that factors that activate NF-{kappa}B can synergize with IFN-{gamma} in promoting endothelial-leukocyte interaction.


Key Words: endothelium • adhesion molecules • cytokines • inflammation




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
V. Fuster, P. R. Moreno, Z. A. Fayad, R. Corti, and J. J. Badimon
Atherothrombosis and High-Risk Plaque: Part I: Evolving Concepts
J. Am. Coll. Cardiol., September 20, 2005; 46(6): 937 - 954.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
H. M. Dansky, P. Shu, M. Donavan, J. Montagno, D. L. Nagle, J. S. Smutko, N. Roy, S. Whiteing, J. Barrios, T. J. McBride, et al.
A Phenotype-Sensitizing Apoe-Deficient Genetic Background Reveals Novel Atherosclerosis Predisposition Loci in the Mouse
Genetics, April 1, 2002; 160(4): 1599 - 1608.
[Abstract] [Full Text] [PDF]